Delivra Health Brands Inc. (TSXV:DHB)
0.0750
-0.0050 (-6.25%)
Nov 20, 2026, 10:50 AM EST
Delivra Health Brands Ratios and Metrics
Market cap in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 2 | 3 | 6 | 11 | 3 | 8 | |
Market Cap Growth | -74.14% | -45.95% | -47.14% | 333.13% | -66.67% | -71.43% |
Enterprise Value | 2 | 3 | 5 | 10 | 1 | 8 |
Last Close Price | 0.08 | 0.10 | 0.18 | 0.35 | 0.10 | 0.30 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | - | - | - | 12.49 | - | - |
Forward PE | - | 19.09 | 63.00 | 63.00 | 63.00 | 63.00 |
PS Ratio | 0.29 | 0.36 | 0.43 | 0.88 | 0.26 | 0.93 |
PB Ratio | 1.12 | 1.41 | 1.36 | 2.11 | 0.75 | 2.25 |
P/TBV Ratio | 1.12 | 1.41 | 1.36 | 2.73 | 2.74 | - |
P/FCF Ratio | - | - | - | 14.47 | - | - |
P/OCF Ratio | - | - | - | 14.47 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.24 | 0.33 | 0.34 | 0.77 | 0.15 | 0.98 |
EV/EBITDA Ratio | - | - | 10.58 | 15.96 | - | - |
EV/FCF Ratio | - | - | - | 12.64 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 1.08 | 1.08 | 0.50 | 0.39 | 0.58 | 0.63 |
Debt / EBITDA Ratio | - | - | 4.95 | 3.38 | - | - |
Debt / FCF Ratio | - | - | - | 2.68 | - | - |
Net Debt / Equity Ratio | -0.20 | -0.20 | -0.28 | -0.42 | -0.23 | 0.30 |
Net Debt / EBITDA Ratio | 0.22 | 0.22 | -2.78 | -3.63 | 23.49 | -0.25 |
Net Debt / FCF Ratio | 0.69 | 0.69 | 1.58 | -2.87 | 0.71 | -0.22 |
Asset Turnover | 1.04 | 1.04 | 1.36 | 1.20 | 0.88 | 0.53 |
Inventory Turnover | 2.18 | 2.18 | 3.11 | 3.20 | 2.22 | 2.46 |
Quick Ratio | 1.78 | 1.78 | 1.87 | 2.33 | 1.00 | 0.43 |
Current Ratio | 2.62 | 2.62 | 2.69 | 2.85 | 1.45 | 1.14 |
Return on Equity (ROE) | -69.75% | -69.75% | -25.23% | 20.41% | -5.44% | -105.00% |
Return on Assets (ROA) | -27.27% | -27.27% | -12.11% | 8.50% | -1.66% | -45.74% |
Return on Capital Employed (ROCE) | -48.10% | -48.10% | -13.90% | -10.20% | -26.80% | -119.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 20, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | -96.13% | -72.10% | -20.58% | 8.01% | -7.28% | -92.48% |
FCF Yield | -25.47% | -20.38% | -13.04% | 6.91% | -43.07% | -58.73% |
Buyback Yield / Dilution | - | - | -9.44% | -13.08% | - | -11.80% |